We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
-3.99%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$3.53B
AUM Growth
-$528M
Cap. Flow
-$324M
Cap. Flow %
-9.18%
Top 10 Hldgs %
29.69%
Holding
1,565
New
259
Increased
499
Reduced
543
Closed
256

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Energy 11.87%
3 Healthcare 10.76%
4 Industrials 6.89%
5 Consumer Discretionary 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITT icon
876
ITT
ITT
$17.1B
$105K ﹤0.01%
1,076
+253
+31% +$24.8K
MGNX icon
877
MacroGenics
MGNX
$233M
$105K ﹤0.01%
22,456
-1,078
-5% -$5.37K
SMMT icon
878
Summit Therapeutics
SMMT
$10.2B
$105K ﹤0.01%
55,960
-18,073
-24% -$34.5K
BPMC
879
DELISTED
Blueprint Medicines
BPMC
$104K ﹤0.01%
2,067
-371
-15% -$19.8K
BB icon
880
BlackBerry
BB
$4.58B
$103K ﹤0.01%
+21,864
New +$107K
IMCR icon
881
Immunocore
IMCR
$1.7B
$103K ﹤0.01%
1,982
-494
-20% -$29.2K
EQRX
882
DELISTED
EQRx, Inc. Common Stock
EQRX
$102K ﹤0.01%
46,099
-28,713
-38% -$61.5K
CPT icon
883
Camden Property Trust
CPT
$11.5B
$102K ﹤0.01%
1,082
+51
+5% +$5.42K
SNX icon
884
TD Synnex
SNX
$19.9B
$102K ﹤0.01%
1,021
+38
+4% +$3.76K
XNCR icon
885
Xencor
XNCR
$1.45B
$102K ﹤0.01%
5,058
-170
-3% -$3.87K
PRLD icon
886
Prelude Therapeutics
PRLD
$375M
$102K ﹤0.01%
32,907
+7,479
+29% +$28.1K
NUVL
887
DELISTED
Nuvalent
NUVL
$102K ﹤0.01%
2,210
-1,039
-32% -$46.1K
TSVT
888
DELISTED
2seventy bio
TSVT
$101K ﹤0.01%
25,838
+13,802
+115% +$90.5K
MRUS
889
DELISTED
Merus
MRUS
$101K ﹤0.01%
4,294
-1,125
-21% -$27.3K
BCYC
890
Bicycle Therapeutics
BCYC
$269M
$101K ﹤0.01%
5,021
-255
-5% -$5.83K
FATE icon
891
Fate Therapeutics
FATE
$275M
$101K ﹤0.01%
47,566
+21,955
+86% +$72.7K
EIX icon
892
Edison International
EIX
$30.3B
$101K ﹤0.01%
1,592
+445
+39% +$31K
BNTX icon
893
BioNTech
BNTX
$23.5B
$101K ﹤0.01%
926
-304
-25% -$33.6K
GERN icon
894
Geron
GERN
$898M
$100K ﹤0.01%
47,351
+3,749
+9% +$10.2K
REPL icon
895
Replimune Group
REPL
$454M
$100K ﹤0.01%
5,849
-49
-0.8% -$962
IMRX icon
896
Immuneering
IMRX
$262M
$99.8K ﹤0.01%
12,999
-1,885
-13% -$17.3K
AURA icon
897
Aura Biosciences
AURA
$725M
$99.8K ﹤0.01%
11,121
-305
-3% -$3.28K
PGEN icon
898
Precigen
PGEN
$1.94B
$99.7K ﹤0.01%
70,232
-37,453
-35% -$53.1K
APLM icon
899
Apollomics
APLM
$38.4M
$99.7K ﹤0.01%
266
-30
-10% -$14.7K
IMTX icon
900
Immatics
IMTX
$1.23B
$99.4K ﹤0.01%
8,585
-3,231
-27% -$38.6K

Similar funds

Exchange Traded Concepts's Q3 2023 Portfolio in Review

As of Q3 2023, Exchange Traded Concepts held 1,565 positions worth $3.53B, down 13% from $4.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exchange Traded Concepts withdrew a net $324M in Q3 2023, closing 256 positions and reducing 543 holdings. Its most notable exit was Vanguard Long-Term Bond ETF, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Exchange Traded Concepts opened a new position in Goldman Sachs Access Treasury 0-1 Year ETF worth $366M.

  • Exchange Traded Concepts's largest Q3 2023 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 3,652,937 shares worth $366M.
  • Exchange Traded Concepts added most to iShares 0-3 Month Treasury Bond ETF in Q3 2023, an estimated $365M increase.
  • Exchange Traded Concepts's biggest Q3 2023 reduction was National Instruments Corp, cutting an estimated $19.2M.
  • Exchange Traded Concepts fully exited Vanguard Long-Term Bond ETF in Q3 2023, selling an estimated $158M.
  • Exchange Traded Concepts's ten largest holdings make up 30% of its $3.53B portfolio in Q3 2023.
  • Exchange Traded Concepts opened 259 new positions and closed 256 in Q3 2023.
  • Exchange Traded Concepts's portfolio value fell 13% quarter-over-quarter to $3.53B.

Based on Exchange Traded Concepts's 13F filing for Q3 2023, filed 18 Oct 2023.